Advertisement

Topics

Dermira gains certain rights to Roche MAb in up to $1.4 billion deal

08:09 EDT 9 Aug 2017 | thePharmaLetter

Shares of US biotech Dermira were down 13.36% at $22.43 by close of trading Tuesday, after it revealed…

Original Article: Dermira gains certain rights to Roche MAb in up to $1.4 billion deal

NEXT ARTICLE

More From BioPortfolio on "Dermira gains certain rights to Roche MAb in up to $1.4 billion deal"

Quick Search
Advertisement
 

Relevant Topic

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...